The Research Integrity and Oversight Program (RIOP) is pleased to announce a new name: As of July 2012, the program’s name is Research Education and Oversight (REO) — and with the name change comes an all-new website.

The Using Controlled Substances for Research policy is currently under review. Therefore, the requirement for Minnesota Board of Pharmacy registrations will be delayed until further notice.

The National Institutes of Health has established new stipend levels for fiscal 2012 Kirschstein National Research Service Awards. All University of Minnesota units and departments that employ graduate research assistants are required to abide by this cap.

Some changes are being implemented in the Research Integrity and Oversight Programs (RIOP) unit in the Office of the Vice President for Research (OVPR). Michele Chin-Purcell, executive director of RIOP, will be leaving the University on Tues., Oct. 5, for a position at Corventis, a startup medical device company located in St. Paul. Over the […]

Presentations will by offered by the Minnesota North Central Regional chapter of the Society of Clinical Research Associates on Tuesday, September 21, 2010, from 3:00-7:30 p.m. Topics and presenters include: Timothy Philips, B.S. Compliance Officer/Biomedical Engineer, FDA – Minneapolis District FDA Operations, Inspections, and Enforcement Learning Objectives:  At the end of this presentation, attendees should […]